Integrative Oncology News
Report Card on Complementary Therapies for Breast Cancer
November 7, 2014 — Over eighty percent of breast cancer patients in the United States use complementary therapies following a breast cancer diagnosis, but there has been little science-based guidance to inform clinicians and patients about their safety and effectiveness. In newly published guidelines from the Society for Integrative Oncology, researchers at Columbia University’s Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center with colleagues at MD Anderson Cancer Center, University of Michigan, Memorial Sloan Kettering, and other institutions in the U.S. and Canada, analyzed which integrative treatments appear to be most effective and safe for patients. They evaluated more than 80 different therapies.
JNCI and SIO Partner to Bring Focus on the Role of Integrative Oncology for Cancer Survivorship at International Conference
More than ever, cancer survivors seek evidence-based information in order to incorporate integrative medicine into conventional cancer care to help improve their outcomes in terms of controlling disease and improving aspects of quality of life in the areas of mind, body and spirit.